Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Feb;24(2):e202300244.
doi: 10.1002/tcr.202300244. Epub 2023 Sep 5.

Dihydroazolopyrimidines: Past, Present and Perspectives in Synthesis, Green Chemistry and Drug Discovery

Affiliations
Review

Dihydroazolopyrimidines: Past, Present and Perspectives in Synthesis, Green Chemistry and Drug Discovery

Serhiy M Desenko et al. Chem Rec. 2024 Feb.

Abstract

Dihydroazolopyrimidines are an important class of heterocycles that are isosteric to natural purines and are therefore of great interest primarily as drug-like molecules. In contrast to the heteroaromatic analogs, synthetic approaches to these compounds were developed much later, and their chemical properties and biological activity have not been studied in detail until recently. In the review, different ways to build dihydroazolopyrimidine systems from different building blocks are described - via the initial formation of a partially hydrogenated pyrimidine ring or an azole ring, as well as a one-pot assembly of azole and azine fragments. Special attention is given to modern approaches: multicomponent reactions, green chemistry, and the use of non-classical activation methods. Information on the chemical properties of dihydroazolopyrimidines and the prospects for their use in the design of drugs of various profiles are also summarized in this review.

Keywords: biological activity; catalyst; dihydroazolopyrimidine; green chemistry; heterocyclization.

PubMed Disclaimer

References

    1. D. G. Brown, J. Boström, J. Med. Chem. 2016, 59, 4443-4458.
    1. S. M. Mennen, C. Alhambra, C. L. Allen, M. Barberis, S. Berritt, T. A. Brandt, A. D. Campbell, J. Castañón, A. H. Cherney, M. Christensen, D. B. Damon, J. Eugenio de Diego, S. García-Cerrada, P. García-Losada, R. Haro, J. Janey, D. C. Leitch, L. Li, F. Liu, P. C. Lobben, D. W. C. MacMillan, J. Magano, E. McInturff, S. Monfette, R. J. Post, D. Schultz, B. J. Sitter, J. M. Stevens, I. I. Strambeanu, J. Twilton, K. Wang, M. A. Zajac, Org. Process Res. Dev. 2019, 23, 1213-1242.
    1. B. K. Banik, Ed., Green Approaches in Medicinal Chemistry for Sustainable Drug Design, Elsevier, 2020.
    1. W. Zhang, B. W. Cue, Eds., Green Techniques for Organic Synthesis and Medicinal Chemistry, Wiley, 2012.
    1. M. Henary, C. Kananda, L. Rotolo, B. Savino, E. A. Owens, G. Cravotto, RSC Adv. 2020, 10, 14170-14197.

LinkOut - more resources